Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2005-03-01
2005-03-01
Killos, Paul J. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S152000
Reexamination Certificate
active
06861558
ABSTRACT:
Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
REFERENCES:
patent: 4410520 (1983-10-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 5015639 (1991-05-01), Berger et al.
patent: 5206235 (1993-04-01), Fisher et al.
patent: 5247080 (1993-09-01), Berger et al.
patent: 5486541 (1996-01-01), Sterling et al.
patent: 5502048 (1996-03-01), Chapdelaine et al.
patent: 5519061 (1996-05-01), Youdim et al.
patent: 5532415 (1996-07-01), Youdim et al.
patent: 5656625 (1997-08-01), Bowen et al.
patent: 5672598 (1997-09-01), De et al.
patent: 6191166 (2001-02-01), Audia et al.
patent: 6448229 (2002-09-01), Teal
patent: 0 652 009 (1995-05-01), None
patent: 0 732 399 (1996-09-01), None
patent: 0 778 266 (1997-06-01), None
patent: 210647 (1994-07-01), None
patent: 9822494 (1993-05-01), None
patent: 9509838 (1995-04-01), None
patent: 9513084 (1995-05-01), None
patent: 9620725 (1996-07-01), None
patent: 9620949 (1996-07-01), None
patent: 9622966 (1996-08-01), None
patent: 9639194 (1996-12-01), None
patent: 9730072 (1997-08-01), None
Adams, et al., “Potent and Selective Inhibitors of the Proteasome; Dipeptidyl Boronic Acids.”Biorg. and Med. Chem. Lets.8:333-338 (1998).
Cordell, “β-Amyloid Formation as a Potential Therapeutic Target for Alzheimer's Disease.”Annu. Rev. Pharmacol. Toxicol.34:69-89 (1994).
Lum, et al., “Selective Inhibition of the Chymotrypsin-like Activity of the 20S Proteasome by 5-Methoxy-1-Indanone Dipeptide Benzamides.”Biorg. and Med. Chem. Lets.8:209-214 (1998).
Papadopoulos, et al. “Anodic Oxidation of N-Acyl and N-Alkoxycarbonyl Dipeptide Esters as a Key Step for the Formation of Chiral Heterocyclic Synthetic Building Blocks.”Tetrahedron,47(4/5):563-572 (1991).
Smith, et al. “β-APP Processing as a Therapeutic Target for Alzheimer's Disease.”Current Pharmaceutical Design,3 439-445 (1997).
Waldmann, et al. “Selective Enzymatic Removal of Protecting Groups: The Phenylacetamide as Amino Protecting Group in Phosphopeptide Synthesis.”Tetrahedron Letters,37 (48):8725-8728 (1996).
Wolfe, et al. “A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's Υ-Secretase Activity.”J. Med. Chem.,41:6-9 (1998).
Zhu, J., et al., “A Convergent Synthesis of 14-Membered F-O-G Ring Analogs of the Teicoplanin Binding Pocket via Intramolecular SNAr Reaction”,J. Org. Chem.,(60), pp. 6389-6396 (1995).
Audia James E.
Britton Thomas C.
Droste James J.
Eid Clark Norman
Folmer Beverly K.
Burns Doane , Swecker, Mathis LLP
Elan Pharmaceuticals Inc.
Eli Lilly & Company
Killos Paul J.
LandOfFree
Methods and compounds for inhibiting β-amyloid peptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compounds for inhibiting β-amyloid peptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compounds for inhibiting β-amyloid peptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409976